UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 138

Sortiert nach

Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

JNCI : Journal of the National Cancer Institute, 2009-05, Vol.101 (9), p.644-650

2009

Link zum Volltext

Verfügbarkeit prüfen

Expression of both Estrogen Receptor-beta 1 (ER-β1) and its co-regulator Steroid Receptor RNA Activator Protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with Estrogen Receptor-alpha (ER-α)-Negative Early Breast Cancer (EBC)

Annals of oncology, 2013-08, Vol.24 (8), p.1986-1993

2013

Link zum Volltext

Verfügbarkeit prüfen

Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials

Breast cancer research and treatment, 2013-11, Vol.142 (1), p.143-151

2013

Link zum Volltext

Verfügbarkeit prüfen

Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial

Breast cancer research and treatment, 2011-07, Vol.128 (2), p.401-409

2011

Link zum Volltext

Verfügbarkeit prüfen

A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada—Clinical Trials Group Trial, MA.12)

Annals of oncology, 2010-02, Vol.21 (2), p.283-290

2010

Link zum Volltext

Verfügbarkeit prüfen

Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials

Annals of oncology, 2017-07, Vol.28 (7), p.1560-1568

2017

Link zum Volltext

Verfügbarkeit prüfen

HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

The New England journal of medicine, 2006-05, Vol.354 (20), p.2103-2111

2006

Link zum Volltext

Verfügbarkeit prüfen

A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma

European journal of cancer (1990), 2001-06, Vol.37 (9), p.1096-1103

2001

Link zum Volltext

Verfügbarkeit prüfen

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup

Journal of clinical oncology, 1992-10, Vol.10 (10), p.1579-1591

1992

Link zum Volltext

Verfügbarkeit prüfen

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

The Lancet (British edition), 1997-09, Vol.350 (9082), p.911-917

1997

Link zum Volltext

Verfügbarkeit prüfen

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in Premenopausal women with node-positive breast cancer

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2651-2658

1998

Link zum Volltext

Verfügbarkeit prüfen

Do authors of review articles use systematic methods to identify, assess and synthesize information?

Annals of oncology, 1997-12, Vol.8 (12), p.1185-1195

1997

Link zum Volltext

Verfügbarkeit prüfen

Quality of life in stage II breast cancer: an instrument for clinical trials

Journal of clinical oncology, 1988-12, Vol.6 (12), p.1798-1810

1988

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of topotecan (NSC 609 699) in patients with recurrent or metastatic soft tissue sarcoma

Annals of oncology, 1995-10, Vol.6 (8), p.847-849

1995

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy for metastatic soft tissue sarcomas - another full circle?

British journal of cancer, 1991-07, Vol.64 (1), p.7-9

BRAMWELL, V. H. C

1991

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Chemotherapy With Doxorubicin and Cisplatin in Malignant Fibrous Histiocytoma of Bone: A European Osteosarcoma Intergroup Study

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3260-3269

1999

Link zum Volltext

Verfügbarkeit prüfen

Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma

Cochrane database of systematic reviews, 2003-07 (3), p.CD003293

2003

Link zum Volltext

Verfügbarkeit prüfen

Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases

The Lancet (British edition), 1998-04, Vol.351 (9110), p.1170-1173

1998

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy for adult soft tissue sarcoma: Is there a standard of care?

Journal of clinical oncology, 2001-03, Vol.19 (5), p.1235-1237

Bramwell, V H

2001

Link zum Volltext

Verfügbarkeit prüfen

The role of chemotherapy in osteogenic sarcoma

Critical reviews in oncology/hematology, 1995-08, Vol.20 (1), p.61-85

Bramwell, Vivien H.C.

1995

Link zum Volltext

Verfügbarkeit prüfen

Combined modality management of local and disseminated adult soft tissue sarcomas: A review of 257 cases seen over 10 years at the Christie Hospital & Holt Radium Institute, Manchester

British journal of cancer, 1985-03, Vol.51 (3), p.301-318

1985

Link zum Volltext

Verfügbarkeit prüfen

Cyvadic in advanced soft tissue sarcoma: A randomized study comparing two schedules: A study of the EORTC soft tissue and bone sarcoma group

Cancer, 1984-05, Vol.53 (9), p.1825-1832

1984

Link zum Volltext

Verfügbarkeit prüfen

The functional and clinical roles of osteopontin in cancer and metastasis

Current molecular medicine, 2001-11, Vol.1 (5), p.621

2001

Link zum Volltext

Verfügbarkeit prüfen

Pyomyositis after chemotherapy for breast cancer

American journal of clinical oncology, 2000-02, Vol.23 (1), p.42-44

2000

Link zum Volltext

Verfügbarkeit prüfen

Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma

The New England journal of medicine, 1993-12, Vol.329 (24), p.1770-1776

1993

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(138)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(99)
Science & Technology
(86)
Life Sciences & Biomedicine
(85)
Female
(70)
Oncology
(60)
Biological And Medical Sciences
(57)
Medical Sciences
(54)
Middle Aged
(53)
Adult
(52)
Pharmacology. Drug Treatments
(41)
Chemotherapy
(36)
Antineoplastic Agents
(35)
Sarcoma - Drug Therapy
(35)
Male
(34)
Aged
(33)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(32)
Soft Tissue Neoplasms - Drug Therapy
(28)
Adolescent
(24)
Breast Neoplasms - Drug Therapy
(22)
Drug Evaluation
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

Expression of both Estrogen Receptor-beta 1 (ER-β1) and its co-regulator Steroid Receptor RNA Activator Protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with Estrogen Receptor-alpha (ER-α)-Negative Early Breast Cancer (EBC)

Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials

Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial

A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada—Clinical Trials Group Trial, MA.12)

Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials

HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in Premenopausal women with node-positive breast cancer

Do authors of review articles use systematic methods to identify, assess and synthesize information?

Quality of life in stage II breast cancer: an instrument for clinical trials

Phase II study of topotecan (NSC 609 699) in patients with recurrent or metastatic soft tissue sarcoma

Chemotherapy for metastatic soft tissue sarcomas - another full circle?

Neoadjuvant Chemotherapy With Doxorubicin and Cisplatin in Malignant Fibrous Histiocytoma of Bone: A European Osteosarcoma Intergroup Study

Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma

Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases

Adjuvant chemotherapy for adult soft tissue sarcoma: Is there a standard of care?

The role of chemotherapy in osteogenic sarcoma

Combined modality management of local and disseminated adult soft tissue sarcomas: A review of 257 cases seen over 10 years at the Christie Hospital & Holt Radium Institute, Manchester

Cyvadic in advanced soft tissue sarcoma: A randomized study comparing two schedules: A study of the EORTC soft tissue and bone sarcoma group

The functional and clinical roles of osteopontin in cancer and metastasis

Pyomyositis after chemotherapy for breast cancer

Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma

Suchergebnisse filtern